We are live on ! Find out more
Rathbones Group

Rathbones Group Portfolio holdings

AUM $27.1B Turnover 12.71%
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.19%
AUM
$27.1B
AUM Growth
+$2.1B
Cap. Flow
+$4.87M
Cap. Flow %
0.02%
Top 10 Hldgs %
39.99%
Holding
700
New
54
Increased
201
Reduced
274
Closed
35
Avg Time Held
4.9 years
Top 10 Avg Time Held
5.7 years
Top 20 Avg Time Held
4.7 years

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$132M
2
NVDA icon
NVIDIA
NVDA
+$67.5M
3
MRSH icon
Marsh
MRSH
+$62.9M
4
GS icon
Goldman Sachs
GS
+$61.9M
5
MNST icon
Monster Beverage
MNST
+$60.8M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$78.9M
2
ACN icon
Accenture
ACN
+$78.2M
3
ORLY icon
O'Reilly Automotive
ORLY
+$75.1M
4
BRO icon
Brown & Brown
BRO
+$69.8M
5
BR icon
Broadridge
BR
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 26.91%
2 Financials 18.06%
3 Healthcare 13.92%
4 Communication Services 9.24%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XLE icon
351
State Street Energy Select Sector SPDR ETF
XLE
$44.8B
$1.18M ﹤0.01%
22,211
+3,915
+21% +$224K
2026 Q1
1 quarter
IXC icon
352
iShares Global Energy ETF
IXC
$3.33B
$1.16M ﹤0.01%
23,603
-246
-1% -$13.3K
2014 Q1
49 quarters
WDFC icon
353
WD-40
WDFC
$2.59B
$1.13M ﹤0.01%
4,635
– –
2025 Q1
5 quarters
KHC icon
354
The Kraft Heinz Company
KHC
$27.8B
$1.12M ﹤0.01%
47,588
-750
-2% -$17.3K
2015 Q3
43 quarters
ORMP icon
355
Oramed Pharmaceuticals
ORMP
$172M
$1.12M ﹤0.01%
233,018
– –
2023 Q3
11 quarters
CNQ icon
356
Canadian Natural Resources
CNQ
$113B
$1.12M ﹤0.01%
28,308
-194
-0.7% -$8.82K
2024 Q3
7 quarters
PXF icon
357
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.94B
$1.1M ﹤0.01%
14,600
– –
2023 Q3
11 quarters
ITA icon
358
iShares US Aerospace & Defense ETF
ITA
$11.8B
$1.1M ﹤0.01%
4,541
+305
+7% +$69.5K
2023 Q3
11 quarters
DFTX icon
359
Definium Therapeutics
DFTX
$4.76B
$1.07M ﹤0.01%
22,800
-7,400
-25% -$183K
2023 Q3
11 quarters
AON icon
360
Aon
AON
$62.4B
$1.06M ﹤0.01%
3,210
+36
+1% +$11.6K
2025 Q2
4 quarters
SKYY icon
361
First Trust Cloud Computing ETF
SKYY
$3.45B
$1.06M ﹤0.01%
7,886
-200
-2% -$25.4K
2020 Q3
23 quarters
IREN icon
362
Iris Energy
IREN
$11.1B
$1.06M ﹤0.01%
23,129
-3,192
-12% -$166K
2025 Q3
3 quarters
JLL icon
363
Jones Lang LaSalle
JLL
$14B
$1.05M ﹤0.01%
3,378
– –
2023 Q3
11 quarters
SLV icon
364
iShares Silver Trust
SLV
$27.9B
$1.04M ﹤0.01%
19,506
-2,000
-9% -$133K
2023 Q3
11 quarters
ASTS icon
365
AST SpaceMobile
ASTS
$12.2B
$1.04M ﹤0.01%
11,736
+215
+2% +$18.8K
2023 Q4
10 quarters
TRP icon
366
TC Energy
TRP
$65.3B
$1.04M ﹤0.01%
15,638
+760
+5% +$50.3K
2024 Q2
8 quarters
TRV icon
367
Travelers Companies
TRV
$82.9B
$1.03M ﹤0.01%
3,111
+1,745
+128% +$529K
2024 Q1
9 quarters
CORT icon
368
Corcept Therapeutics
CORT
$12.6B
$1.03M ﹤0.01%
+11,790
New +$712K
2026 Q2
0 quarters
SLF icon
369
Sun Life Financial
SLF
$44.8B
$1.02M ﹤0.01%
13,025
+75
+0.6% +$5.4K
2022 Q3
15 quarters
DAVA icon
370
Endava
DAVA
$113M
$1.02M ﹤0.01%
360,823
– –
2021 Q2
20 quarters
WAT icon
371
Waters Corp
WAT
$44.9B
$1.01M ﹤0.01%
2,692
-458
-15% -$156K
2026 Q1
1 quarter
VGIT icon
372
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.9B
$999K ﹤0.01%
16,935
– –
2025 Q4
2 quarters
BKR icon
373
Baker Hughes
BKR
$55.9B
$997K ﹤0.01%
17,969
– –
2022 Q1
17 quarters
CPNG icon
374
Coupang
CPNG
$24.9B
$970K ﹤0.01%
55,817
-1,775
-3% -$32K
2025 Q4
2 quarters
VEU icon
375
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
$966K ﹤0.01%
11,533
+802
+7% +$65.5K
2023 Q3
11 quarters
13 14
15
16 17

Similar funds

NEOS Investment Management
NEOS Investment Management Westport, Connecticut $27.1B AUM 57.21% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Rokos Capital Management (UK)
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
Scotia Capital
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Rathbones Group's Q2 2026 Portfolio in Review

As of Q2 2026, Rathbones Group held 700 positions worth $27.1B, up 8.4% from $25B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rathbones Group's Q2 2026 filing shows 54 new, 201 increased, 274 reduced and 35 closed positions. Its largest new stake was Monster Beverage: 1,447,724 shares worth $69.6M. The largest sale was Intuit, an estimated $78.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2026 buy was Monster Beverage: 1,447,724 shares worth $69.6M.
  • Rathbones Group added most to Lam Research in Q2 2026, an estimated $132M increase.
  • Rathbones Group's biggest Q2 2026 reduction was Intuit, cutting an estimated $78.9M.
  • Rathbones Group fully exited Broadridge in Q2 2026, selling an estimated $65.4M.
  • Rathbones Group's ten largest holdings make up 40% of its $27.1B portfolio in Q2 2026.
  • Rathbones Group opened 54 new positions and closed 35 in Q2 2026.
  • Rathbones Group's portfolio value rose 8.4% quarter-over-quarter to $27.1B.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.